Recent progress on liver kinase B1 (LKB1): Expression, regulation, downstream signaling and cancer suppressive function

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 16698-16718

  Gan, Ren You ^a   Li, Hua Bin ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

AMPK; Cancer; Liver kinase B1; LKB1; MARK

Indexed keywords

ATM PROTEIN; BINDING PROTEIN; BRAIN SELECTIVE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CELECOXIB; CELL CYCLE PROTEIN 37; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN 90; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER ENZYME; LIVER KINASE B1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METFORMIN; MICROTUBULE AFFINITY REGULATING KINASE; MICROTUBULE ASSOCIATED PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 4; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN P53; PROTEINASE ACTIVATED RECEPTOR 1; RAPAMYCIN; SALT INDUCIBLE KINASE; SIRTUIN 1; SUCROSE NON FERMENTING PROTEIN RELATED KINASE; SYNAPSES OF AMPHIDS DEFICIENT KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; CHAPERONE; PROTEIN BINDING; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; SEX HORMONE; STK11 PROTEIN, HUMAN; STK11 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELLULAR DISTRIBUTION; DNA METHYLATION; ENZYME REGULATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HUMAN; KNOCKOUT GENE; METASTASIS; NEOPLASM; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL CYCLE; DEFICIENCY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HORMESIS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PEUTZ JEGHERS SYNDROME; PHYSIOLOGY; PROMOTER REGION; PROTEIN ANALYSIS; SPECIES DIFFERENCE;

ANIMALS; CELL CYCLE; CELL DEATH; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GONADAL STEROID HORMONES; HORMESIS; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; NEOPLASM METASTASIS; PEUTZ-JEGHERS SYNDROME; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TUMOR SUPPRESSOR PROTEINS;

EID: 84907870409     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150916698     Document Type: Review

References (123)

1. Hemminki, A.; Markie, D.; Tomlinson, I.; Avizienyte, E.; Roth, S.; Loukola, A.; Bignell, G.; Warren, W.; Aminoff, M.; Hoglund, P.; et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391, 184-187.
2. Jenne, D. E.; Reimann, H.; Nezu, J.; Friedel, W.; Loff, S.; Jeschke, R.; Muller, O.; Back, W.; Zimmer, M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 1998, 18, 38-43.
3. Avizienyte, E.; Roth, S.; Loukola, A.; Hemminki, A.; Lothe, R. A.; Stenwig, A. E.; Fossa, S. D.; Salovaara, R.; Aaltonen, L. A. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res. 1998, 58, 2087-2090.
4. Park, W. S.; Moon, Y. W.; Yang, Y. M.; Kim, Y. S.; Kim, Y. D.; Fuller, B. G.; Vortmeyer, A. O.; Fogt, F.; Lubensky, I. A.; Zhuang, Z. P. Mutations of the STK11 gene in sporadic gastric carcinoma. Int. J. Oncol. 1998, 13, 601-604.
5. Avizienyte, E.; Loukola, A.; Roth, S.; Hemminki, A.; Tarkkanen, M.; Salovaara, R.; Arola, J.; Butzow, R.; Husgafvel-Pursiainen, K.; Kokkola, A.; et al. LKB1 somatic mutations in sporadic tumors. Am. J. Pathol. 1999, 154, 677-681.
6. Sanchez-Cespedes, M.; Parrella, P.; Esteller, M.; Nomoto, S.; Trink, B.; Engles, J. M.; Westra, W. H.; Herman, J. G.; Sidransky, D. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 2002, 62, 3659-3662.
7. Bignell, G. R.; Barfoot, R.; Seal, S.; Collins, N.; Warren, W.; Stratton, M. R. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res. 1998, 58, 1384-1386.
8. Baty, D.; Forster, L. F.; Defres, S.; Goudie, D.; Carey, F. A. Involvement of the Peutz-Jeghers syndrome gene LKB1 in breast and colon cancer. J. Med. Genet. 1999, 36, S46-S46.
9. Hruban, R. H.; Petersen, G. M.; Goggins, M.; Tersmette, A. C.; Offerhaus, G. J. A.; Falatko, F.; Yeo, C. J.; Kern, S. E. Familial pancreatic cancer. Ann. Oncol. 1999, 10, 69-73.
10. Su, G. H.; Hruban, R. H.; Bansal, R. K.; Bova, G. S.; Tang, D. J.; Shekher, M. C.; Westerman, A. M.; Entius, M. M.; Goggins, M.; Yeo, C. J.; et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol. 1999, 154, 1835-1840.
11. Guldberg, P.; Straten, P. T.; Ahrenkiel, V.; Seremet, T.; Kirkin, A. F.; Zeuthen, J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 1999, 18, 1777-1780.
12. Rowan, A.; Bataille, V.; MacKie, R.; Healy, E.; Bicknell, D.; Bodmer, W.; Tomlinson, I. Somatic mutations in the Peutz-Jegners (LKB1/STKII) gene in sporadic malignant melanomas. J. Investig. Dermatol. 1999, 112, 509-511.
13. Qiu, W.; Schonleben, F.; Thaker, H. M.; Goggins, M.; Su, G. H. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 2006, 25, 2937-2942.
14. Kim, C. J.; Cho, Y. G.; Park, J. Y.; Kim, T. Y.; Lee, J. H.; Kim, H. S.; Lee, J. W.; Song, Y. H.; Nam, S. W.; Lee, S. H.; et al. Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur. J. Cancer 2004, 40, 136-141.
15. Ylikorkala, A.; Rossi, D. J.; Korsisaari, N.; Luukko, K.; Alitalo, K.; Henkemeyer, M.; Makela, T. P. Vascular abnormalities and deregulation of VEGF in LKB1-deficient mice. Science 2001, 293, 1323-1326.
16. Jishage, K.; Nezu, J.; Kawase, Y.; Iwata, T.; Watanabe, M.; Miyoshi, A.; Ose, A.; Habu, K.; Kake, T.; Kamada, N.; et al. Role of LKB1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc. Natl. Acad. Sci. USA 2002, 99, 8903-8908.
17. Miyoshi, H.; Nakau, M.; Ishikawa, T.; Seldin, M. F.; Oshima, M.; Taketo, M. M. Gastrointestinal hamartomatous polyposis in LKB1 heterozygous knockout mice. Cancer Res. 2002, 62, 2261-2266.
18. Nakau, M.; Miyoshi, H.; Seldin, M. F.; Imamura, M.; Oshima, M.; Taketo, M. M. Hepatocellular carcinoma caused by loss of heterozygosity in LKB1 gene knockout mice. Cancer Res. 2002, 62, 4549-4553.
19. Rossi, D. J.; Ylikorkala, A.; Korsisaari, N.; Salovaara, R.; Luukko, K.; Launonen, V.; Henkemeyer, M.; Ristimaki, A.; Aaltonen, L. A.; Makela, T. P. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl. Acad. Sci. USA 2002, 99, 12327-12332.
20. Koh, H. J.; Arnolds, D. E.; Fujii, N.; Tran, T. T.; Rogers, M. J.; Jessen, N.; Li, Y. F.; Liew, C. W.; Ho, R. C.; Hirshman, M. F.; et al. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves, glucose homeostasis, and decreases TRB3. Mol. Cell. Biol. 2006, 26, 8217-8227.
21. Londesborough, A.; Vaahtomeri, K.; Tiainen, M.; Katajisto, P.; Ekman, N.; Vallenius, T.; Makela, T. P. LKB1 in endothelial cells is required for angiogenesis and TGFβ-mediated vascular smooth muscle cell recruitment. Development 2008, 135, 2331-2338.
22. Vaahtomeri, K.; Ventela, E.; Laajanen, K.; Katajisto, P.; Wipff, P. J.; Hinz, B.; Vallenius, T.; Tiainen, M.; Makela, T. P. LKB1 is required for TGFβ-mediated myofibroblast differentiation. J. Cell Sci. 2008, 121, 3531-3540.
23. Towler, M. C.; Fogarty, S.; Hawley, S. A.; Pan, D. A.; Martin, D. M. A.; Morrice, N. A.; McCarthy, A.; Galardo, M. N.; Meroni, S. B.; Cigorraga, S. B.; et al. A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis. Biochem. J. 2008, 416, 1-14.
24. Robinson, J.; Nye, E.; Stamp, G.; Silver, A. Osteogenic tumours in LKB1-deficient mice. Exp. Mol. Pathol. 2008, 85, 223-226.
25. Pearson, H. B.; McCarthy, A.; Collins, C. M. P.; Ashworth, A.; Clarke, A. R. LKB1 deficiency causes prostate neoplasia in the mouse. Cancer Res. 2008, 68, 2223-2232.
26. Denison, F. C.; Smith, L. B.; Muckett, P. J.; O'Hara, L.; Carling, D.; Woods, A. LKB1 is an essential regulator of spermatozoa release during spermiation in the mammalian testis. PLoS One 2011, 6, e28306.
27. Tanwar, P. S.; Kaneko-Tarui, T.; Zhang, L.; Tanaka, Y.; Crum, C. P.; Teixeira, J. M. Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian target of Rapamycin complex 1. PLoS Genet. 2012, 8, e1002906.
28. Tanwar, P. S.; Kaneko-Tarui, T.; Zhang, L.; Teixeira, J. M. Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis. Hum. Mol. Genet. 2012, 21, 4394-4405.
29. Zhang, W.; Wang, Q.; Song, P.; Zou, M. Liver kinase B1 is required for white adipose tissue growth and differentiation. Diabetes 2013, 62, 2347-2358.
30. Jeppesen, J.; Maarbjerg, S. J.; Jordy, A. B.; Fritzen, A. M.; Pehmoller, C.; Sylow, L.; Serup, A. K.; Jessen, N.; Thorsen, K.; Prats, C.; et al. LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes 2013, 62, 1490-1499.
31. Andrade-Vieira, R.; Xu, Z.; Colp, P.; Marignani, P. A. Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways. PLoS One 2013, 8, e56567.
32. Mehenni, H.; Gehrig, C.; Nezu, J.; Oku, A.; Shimane, M.; Rossier, C.; Guex, N.; Blouin, J. L.; Scott, H. S.; Antonarakis, S. E. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 1998, 63, 1641-1650.
33. Smith, D. P.; Spicer, J.; Smith, A.; Swift, S.; Ashworth, A. The mouse Peutz-Jeghers syndrome gene LKB1 encodes a nuclear protein kinase. Hum. Mol. Genet. 1999, 8, 1479-1485.
34. Su, J. Y.; Erikson, E.; Maller, J. L. Cloning and characterization of a novel serine/threonine protein kinase expressed in early Xenopus embryos. J. Biol. Chem. 1996, 271, 14430-14437.
35. Watts, J. L.; Morton, D. G.; Bestman, J.; Kemphues, K. J. The C. elegans Par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development 2000, 127, 1467-1475.
36. Martin, S. G.; St Johnston, D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 2003, 421, 379-384.
37. Churchman, M.; Dowling, B.; Tomlinson, I. P. M. Identification of a novel mRNA species of the LKB1/STK11 Peutz-Jeghers serine/threonine kinase. DNA Seq. 1999, 10, 255-261.
38. Abed, A. A.; Gunther, K.; Kraus, C.; Hohenberger, W.; Ballhausen, W. G. Mutation screening at the RNA level of the STK11/LKB-1 gene in Peutz-Jeghers syndrome reveals complex splicing abnormalities and a novel mRNA isoform (STK11 c. 597 (boolean AND) 598insIVS4). Hum. Mut. 2001, 18, 397-410.
39. Luukko, K.; Ylikorkala, A.; Tiainen, M.; Makela, T. P. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development. Mech. Dev. 1999, 83, 187-190.
40. Rowan, A.; Churchman, M.; Jefferey, R.; Hanby, A.; Poulsom, R.; Tomlinson, I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J. Pathol. 2000, 192, 203-206.
41. Ylikorkala, A.; Avizienyte, E.; Tomlinson, I. P. M.; Tiainen, M.; Roth, S.; Loukola, A.; Hemminki, A.; Johansson, M.; Sistonen, P.; Markie, D.; et al. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 1999, 8, 45-51.
42. Collins, S. P.; Reoma, J. L.; Gamm, D. M.; Uhler, M. D. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem. J. 2000, 345, 673-680.
43. Nezu, J.; Oku, A.; Shimane, M. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem. Biophys. Res. Commun. 1999, 261, 750-755.
44. Tiainen, M.; Vaahtomeri, K.; Ylikorkala, A.; Makela, T. P. Growth arrest by the LKB1 tumor suppressor: Induction of p21 (WAF1/CIP1). Hum. Mol. Genet. 2002, 11, 1497-1504.
45. Karuman, P.; Gozani, O.; Odze, R. D.; Zhou, X. C.; Zhu, H.; Shaw, R.; Brien, T. P.; Bozzuto, C. D.; Ooi, D.; Cantley, L. C.; et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol. Cell 2001, 7, 1307-1319.
46. Qanungo, S.; Haldar, S.; Basu, A. Restoration of silences Peutz-Jeghers syndrome gene, LKB1 induces apoptosis in pancreatic carinoma cells. Neoplasia 2003, 5, 367-374.
47. Brajenovic, M.; Joberty, G.; Kuster, B.; Bouwmeester, T.; Drewes, G. Comprehensive proteomic analysis of human par protein complexes reveals an interconnected protein network. J. Biol. Chem. 2004, 279, 12804-12811.
48. Smith, D. P.; Rayter, S. I.; Niederlander, C.; Spicer, J.; Jones, C. M.; Ashworth, A. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum. Mol. Genet. 2001, 10, 2869-2877.
49. Baas, A. F.; Boudeau, J.; Sapkota, G. P.; Smit, L.; Medema, R.; Morrice, N. A.; Alessi, D. R.; Clevers, H. C. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J. 2003, 22, 3062-3072.
50. Boudeau, J.; Baas, A. F.; Deak, M.; Morrice, N. A.; Kieloch, A.; Schutkowski, M.; Prescott, A. R.; Clevers, H. C.; Alessi, D. R. MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003, 22, 5102-14.
51. Boudeau, J.; Scott, J. W.; Resta, N.; Deak, M.; Kieloch, A.; Komander, D.; Hardie, D. G.; Prescott, A. R., van Aalten, D. M. F.; Alessi, D. R. Analysis of the LKB1-STRAD-MO25 complex. J. Cell Sci. 2004, 117, 6365-6375.
52. Zeqiraj, E.; Filippi, B. M.; Deak, M.; Alessi, D. R.; van Aalten, D. M. F. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science 2009, 326, 1707-1711.
53. Milburn, C. C.; Boudeau, J.; Deak, M.; Alessi, D. R.; van Aalten, D. M. F. Crystal structure of MO25α in complex with the C terminus of the pseudo kinase STE20-related adaptor. Nat. Struct. Mol. Biol. 2004, 11, 193-200.
54. Nony, P.; Gaude, H.; Rossel, M.; Fournier, L.; Rouault, J. P.; Billaud, M. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37. Oncogene 2003, 22, 9165-9175.
55. Boudeau, J.; Deak, M.; Lawlor, M. A.; Morrice, N. A.; Alessi, D. R. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem. J. 2003, 370, 849-857.
56. Gaude, H.; Aznar, N.; Delay, A.; Bres, A.; Buchet-Poyau, K.; Caillat, C.; Vigouroux, A.; Rogon, C.; Woods, A.; Vanacker, J. M.; et al. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene 2012, 31, 1582-1591.
57. Mehenni, H.; Lin-Marq, N.; Buchet-Poyau, K.; Reymond, A.; Collart, M. A.; Picard, D.; Antonarakis, S. E. LKB1 interacts with and phosphorylates PTEN: A functional link between two proteins involved in cancer predisposing syndromes. Hum. Mol. Genet. 2005, 14, 2209-2219.
58. Marignani, P. A.; Kanai, F.; Carpenter, C. L. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J. Biol. Chem. 2001, 276, 32415-32418.
59. Blumer, J. B.; Bernard, M. L.; Peterson, Y. K.; Nezu, J.; Chung, P.; Dunican, D. J.; Knoblich, J. A.; Lanier, S. M. Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression-Phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with G(i)α. J. Biol. Chem. 2003, 278, 23217-23220.
60. Clements, W. K.; Kimelman, D. Wnt signalling gets XEEKy. Nat. Cell Biol. 2003, 5, 861-863.
61. Fernandes, N.; Sun, Y. L.; Chen, S. J.; Paul, P.; Shaw, R. J.; Cantley, L. C.; Price, B. D. DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. J. Biol. Chem. 2005, 280, 15158-15164.
62. Setogawa, T.; Shinozaki-Yabana, S.; Masuda, T.; Matsuura, K.; Akiyama, T. The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1. Biochem. Biophys. Res. Commun. 2006, 343, 1186-1190.
63. Esteller, M.; Avizienyte, E.; Corn, P. G.; Lothe, R. A.; Baylin, S. B.; Aaltonen, L. A.; Herman, J. G. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 2000, 19, 164-168.
64. Trojan, J.; Brieger, A.; Raedle, J.; Esteller, M.; Zeuzem, S. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13. 3 in sporadic colorectal cancer. Gut 2000, 47, 272-276.
65. Brown, K. A.; McInnes, K. J.; Takagi, K.; Ono, K.; Hunger, N. I.; Wang, L.; Sasano, H.; Simpson, E. R. LKB1 expression is inhibited by estradiol-17β in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 2011, 127, 439-443.
66. Linher-Melville, K.; Zantinge, S.; Singh, G. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells. Biochem. Biophys. Res. Commun. 2012, 417, 1063-1068.
67. McInnes, K. J.; Brown, K. A.; Hunger, N. I.; Simpson, E. R. Regulation of LKB1 expression by sex hormones in adipocytes. Int. J. Obes. 2012, 36, 982-985.
68. Han, S. W.; Khuri, F. R.; Roman, J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res. 2006, 66, 315-323.
69. Kimball, S. R.; Siegfried, B. A.; Jefferson, L. S. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J. Biol. Chem. 2004, 279, 54103-54109.
70. Feiger, Z. J.; Maizels, E. T.; Flynn, M. P.; Hunzicker-Dunn, M. FSH elicits C-terminal phosphorylation of the serine threonine kinase LKB1. Biol. Reprod. 2005, 2005, 245-245.
71. Xie, Z. L.; Dong, Y. Z.; Zhang, M.; Cui, M. Z.; Cohen, R. A.; Riek, U.; Neumann, D.; Schlattner, U.; Zou, M. H. Activation of protein kinase Cζ by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 2006, 281, 6366-6375.
72. Sapkota, G. P.; Boudeau, J.; Deak, M.; Kieloch, A.; Morrice, N.; Alessi, D. R. Identification and characterization of four novel phosphorylation sites (Ser(31), Ser(325), Thr(336) and Thr(366)) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem. J. 2002, 362, 481-490.
73. Sapkota, G. P.; Deak, M.; Kieloch, A.; Morrice, N.; Goodarzi, A. A.; Smythe, C.; Shiloh, Y.; Lees-Miller, S. P.; Alessi, D. R. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem. J. 2002, 368, 507-516.
74. Sapkota, G. P.; Kieloch, A.; Lizcano, J. M.; Lain, S.; Arthur, J. S. C.; Williams, M. R.; Morrice, N.; Deak, M.; Alessi, D. R. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser(431) by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth. J. Biol. Chem. 2001, 276, 19469-19482.
75. Zu, Y.; Liu, L.; Lee, M. Y. K.; Xu, C.; Liang, Y.; Man, R. Y.; Vanhoutte, P. M.; Wang, Y. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 2010, 106, 1384-1393.
76. Lan, F.; Cacicedo, J. M.; Ruderman, N.; Ido, Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1-Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 2008, 283, 27628-27635.
77. Hou, X. Y.; Xu, S. Q.; Maitland-Toolan, K. A.; Sato, K.; Jiang, B. B.; Ido, Y. S.; Lan, F.; Walsh, K.; Wierzbicki, M.; Verbeuren, T. J.; et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 2008, 283, 20015-20026.
78. Lizcano, J. M.; Goransson, O.; Toth, R.; Deak, M.; Morrice, N. A.; Boudeau, J.; Hawley, S. A.; Udd, L.; Makela, T. P.; Hardie, D. G.; et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23, 833-843.
79. Jaleel, M.; Villa, F.; Deak, M.; Toth, R.; Prescott, A. R.; van Aalten, D. M. F.; Alessi, D. R. The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation. Biochem. J. 2006, 394, 545-555.
80. Wong, K. A.; Lodish, H. F. A revised model for AMP-activated protein kinase structure-The α-subunit binds to both the β-and γ-subunits although there is no direct binding between the β-and γ-subunits. J. Biol. Chem. 2006, 281, 36434-36442.
81. Hong, S. P.; Leiper, F. C.; Woods, A.; Carling, D.; Carlson, M. Activation of yeast SNF1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. USA 2003, 100, 8839-8843.
82. Shaw, R. J.; Kosmatka, M.; Bardeesy, N.; Hurley, R. L.; Witters, L. A.; DePinho, R. A.; Cantley, L. C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 2004, 101, 3329-3335.
83. Woods, A.; Johnstone, S. R.; Dickerson, K.; Leiper, F. C.; Fryer, L. G. D.; Neumann, D.; Schlattner, U.; Wallimann, T.; Carlson, M.; Carling, D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13, 2004-2008.
84. Drewes, G.; Ebneth, A.; Preuss, U.; Mandelkow, E. M.; Mandelkow, E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 1997, 89, 297-308.
85. Goransson, O.; Deak, M.; Wullschleger, S.; Morrice, N. A.; Prescott, A. R.; Alessi, D. R. Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation. J. Cell Sci. 2006, 119, 4059-4070.
86. Wang, J. W.; Imai, Y.; Lu, B. W. Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. J. Neurosci. 2007, 27, 574-581.
87. Kojima, Y.; Miyoshi, H.; Clevers, H. C.; Oshima, M.; Aoki, M.; Taketo, M. M. Suppression of tubulin polymerization by the LKB1-microtubule-associated protein/microtubule affinity-regulating kinase signaling. J. Biol. Chem. 2007, 282, 23532-23540.
88. Hashimoto, Y. K.; Satoh, T.; Okamoto, M.; Takemori, H. Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J. Cell. Biochem. 2008, 104, 1724-1739.
89. Screaton, R. A.; Conkright, M. D.; Katoh, Y.; Best, J. L.; Canettieri, G.; Jeffries, S.; Guzman, E.; Niessen, S.; Yates, J. R.; Takemori, H.; et al. The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 2004, 119, 61-74.
90. Katoh, Y.; Takemori, H.; Lin, X.; Tamura, M.; Muraoka, M.; Satoh, T.; Tsuchiya, Y.; Min, L.; Doi, J.; Miyauchi, A.; et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 2006, 273, 2730-2748.
91. Shaw, R. J.; Lamia, K. A.; Vasquez, D.; Koo, S. H.; Bardeesy, N.; DePinho, R. A.; Montminy, M.; Cantley, L. C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310, 1642-1646.
92. Jaleel, M.; McBride, A.; Lizcano, J. M.; Deak, M.; Toth, R.; Morrice, N. A.; Alessi, D. R. Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett. 2005, 579, 1417-1423.
93. Lefebvre, D. L.; Rosen, C. F. Regulation of SNARK activity in response to cellular stresses. Biochim. Biophys. Acta 2005, 1724, 71-85.
94. Kuga, W.; Tsuchihara, K.; Ogura, T.; Kanehara, S.; Saito, M.; Suzuki, A.; Esumi, H. Nuclear localization of SNARK; its impact on gene expression. Biochem. Biophys. Res. Commun. 2008, 377, 1062-1066.
95. Yamamoto, H.; Takashima, S.; Shintani, Y.; Yamazaki, S.; Seguchi, O.; Nakano, A.; Higo, S.; Kato, H.; Liao, Y.; Asano, Y.; et al. Identification of a novel substrate for TNFα-induced kinase NUAK2. Biochem. Biophys. Res. Commun. 2008, 365, 541-547.
96. Bright, N. J.; Carling, D.; Thornton, C. Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. J. Biol. Chem. 2008, 283, 14946-14954.
97. Barnes, A. P.; Lilley, B. N.; Pan, Y. A.; Plummer, L. J.; Powell, A. W.; Raines, A. N.; Sanes, J. R.; Polleux, F. LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell 2007, 129, 549-563.
98. Hardie, D. G.; Alessi, D. R. LKB1 and AMPK and the cancer-metabolism link-Ten years after. BMC Biol. 2013, 11, 36.
99. Xiang, X. Q.; Saha, A. K.; Wen, R.; Ruderman, N. B.; Luo, Z. J. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. Biochem. Biophys. Res. Commun. 2004, 321, 161-167.
100. Hardie, D. G. New roles for the LKB1-AMPK pathway. Curr. Opin. Cell Biol. 2005, 17, 167-173.
101. Zakikhani, M.; Dowling, R.; Fantus, I. G.; Sonenberg, N.; Pollak, M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006, 66, 10269-10273.
102. Jones, R. G.; Plas, D. R.; Kubek, S.; Buzzai, M.; Mu, J.; Xu, Y.; Birnbaum, M. J.; Thompson, C. B. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 2005, 18, 283-293.
103. Hwang, J. T.; Kim, Y. M.; Surh, Y. J.; Baik, H. W.; Lee, S. Y.; Ha, J.; Park, O. J. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res. 2006, 66, 10057-10063.
104. Upadhyay, S.; Liu, C. Y.; Chatterjee, A.; Hoque, M. O.; Kim, M. S.; Engles, J.; Westra, W.; Trink, B.; Ratovitski, E.; Sidransky, D. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res. 2006, 66, 7870-7879.
105. Wagner, T. M.; Mullally, J. E.; Fitzpatrick, F. A. Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11-Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation. J. Biol. Chem. 2006, 281, 2598-2604.
106. Zeng, P. Y.; Berger, S. L. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation. Cancer Res. 2006, 66, 10701-10708.
107. Wilson, W. R.; Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11, 393-410.
108. Powis, G.; Kirkpatrick, L. Hypoxia inducible factor-1α as a cancer drug target. Mol. Cancer Ther. 2004, 3, 647-654.
109. Shaw, R. J.; Bardeesy, N.; Manning, B. D.; Lopez, L.; Kasmatka, M.; de Pinho, R. A.; Cantley, L. C. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004, 6, 91-99.
110. Thomas, G. V.; Tran, C.; Mellinghoff, I. K.; Welsbie, D. S.; Chan, E.; Fueger, B.; Czernin, J.; Sawyers, C. L. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat. Med. 2006, 12, 122-127.
111. Shackelford, D. B.; Vasquez, D. S.; Corbeil, J.; Wu, S. L.; Leblanc, M.; Wu, C. L.; Vera, D. R.; Shaw, R. J. mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc. Natl. Acad. Sci. USA 2009, 106, 11137-11142.
112. Lee, J. H.; Koh, H.; Kim, M.; Park, J.; Lee, S. Y.; Lee, S.; Chung, J. JNK pathway mediates apoptotic cell death induced by tumor suppressor LKB1 in Drosophila. Cell Death Differ. 2006, 13, 1110-1122.
113. Takeda, S.; Iwai, A.; Nakashima, M.; Fujikura, D.; Chiba, S.; Li, H. M.; Uehara, J.; Kawaguchi, S.; Kaya, M.; Nagoya, S.; et al. LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma. Anticancer Res. 2007, 27, 761-768.
114. Shaw, R. J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. 2009, 196, 65-80.
115. Zhuang, Z. G.; Di, G. H.; Shen, Z. Z.; Ding, J.; Shao, Z. M. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol. Cancer Res. 2006, 4, 843-849.
116. Taliaferro-Smith, L.; Nagalingam, A.; Zhong, D.; Zhou, W.; Saxena, N. K.; Sharma, D. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 2009, 28, 2621-2633.
117. Udd, L.; Katajisto, P.; Rossi, D. J.; Lepisto, A.; Lahesmaa, A. M.; Ylikorkala, A.; Jarvinen, H. J.; Ristimaki, A. P.; Makela, T. P. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology 2004, 127, 1030-1037.
118. Xiao, X. X.; He, Q. Q.; Lu, C. M.; Werle, K. D.; Zhao, R. X.; Chen, J. F.; Davis, B. C.; Cui, R. T.; Liang, J. Y.; Xu, Z. X. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells. Gynecol. Oncol. 2012, 127, 249-255.
119. Contreras, C. M.; Akbay, E. A.; Gallardo, T. D.; Haynie, J. M.; Sharma, S.; Tagao, O.; Bardeesy, N.; Takahashi, M.; Settleman, J.; Wong, K. K.; et al. LKB1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Dis. Models Mech. 2010, 3, 181-193.
120. Park, S. Y.; Park, O. J. Modulation of cancer cell proliferation by cell survival signal Akt and tumor suppressive energy sensor AMP-activated Protein kinase in colon cancer cells treated with resveratrol. Food Sci. Biotechnol. 2010, 19, 1537-1541.
121. Jeon, S. M.; Chandel, N. S.; Hay, N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485, 661-665.
122. Liu, L.; Ulbrich, J.; Muller, J.; Wustefeld, T.; Aeberhard, L.; Kress, T. R.; Muthalagu, N.; Rycak, L.; Rudalska, R.; Moll, R.; et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 2012, 483, 608-612.
123. Shackelford, D. B.; Abt, E.; Gerken, L.; Vasquez, D. S.; Seki, A.; Leblanc, M.; Wei, L.; Fishbein, M. C.; Czernin, J.; Mischel, P. S.; et al. LKB1 Inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 2013, 23, 143-158.